Related Experiment Video
Updated: Jul 17, 2026
07:22
Glycemic Impact on Knee Osteoarthritis Symptoms on Physical, Radiographic, and Inflammatory Markers among Individuals Aged 50 and Over with Diabetes
Published on: March 7, 2025
[Diabetes and oral osteoporosis]
1Osaka University Graduate School of Dentistry, Department of Oral Frontier Biology.
Clinical Calcium
|February 3, 2007
Summary
Diabetic periodontitis, a severe complication, is worsened by factors like advanced glycation endproducts (AGEs). AGEs also accelerate osteoporosis, critically impacting oral bone health in diabetic patients.
Area of Science:
- Oral health
- Endocrinology
- Periodontology
Background:
- Severe marginal periodontitis is a significant complication of diabetes.
- Diabetic periodontitis is influenced by factors including glycated hemoglobin (HbA1c), advanced glycation endproducts (AGEs), C-reactive protein (CRP), glucose tolerance, and inflammatory cytokines (TNF-α, IL-1β, IL-6).
- Porphyromonas gingivalis, a periodontal pathogen, is also implicated.
Purpose of the Study:
- To investigate the role of diabetes-associated factors in the deterioration of periodontitis.
- To explore the specific association between advanced glycation endproducts (AGEs) and diabetic periodontitis progression.
- To examine the link between AGEs, diabetes, and oral osteoporosis.
Main Methods:
- Review of existing literature on diabetes and periodontitis.
- Analysis of factors contributing to diabetic periodontitis, focusing on AGEs.
- Investigation of the relationship between AGEs, diabetes, and osteoporosis.
Main Results:
- Advanced glycation endproducts (AGEs) show a strong association with the worsening of periodontitis in diabetic individuals.
- AGEs are implicated in accelerating the progression of osteoporosis.
- AGEs are identified as a critical factor in diabetes-related oral osteoporosis.
Conclusions:
- Advanced glycation endproducts (AGEs) play a crucial role in the deterioration of periodontitis in diabetic patients.
- AGEs contribute significantly to the development and progression of oral osteoporosis in the context of diabetes.
- Targeting AGEs may be a key strategy for managing diabetic periodontitis and associated oral bone loss.
Related Concept Videos
01:24Type II Diabetes II: Pathophysiology
PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
01:26Oral Hypoglycemic Agents: Biguanides and Glitazones
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood glucose levels...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:22Complications of Diabetes Mellitus
Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
01:22Diabetes Mellitus: Type 2 and Gestational
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
01:26Type I Diabetes II: Pathophysiology
Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...